Hong Kong’s Wealth for Good Summit to highlight AI, robotics, biotech opportunities



As innovations arise from the artificial intelligence, robotics and biotechnology sectors, holders of family capital from around the world will convene in Hong Kong to discuss such investment opportunities at the city’s fourth annual Wealth for Good Summit on March 23 and 24.

Secretary for Financial Services and the Treasury Christopher Hui Ching-yu said the summit would showcase Hong Kong’s position as a premier hub for family capital seeking long-term growth and multigenerational legacy.

Launched in March 2023 to attract global family offices and high-net-worth individuals, the event this year would bring together top family office leaders and next-generation wealth successors to discuss intergenerational investing, impact investing, philanthropy and family governance, Hui said in a blog post on Thursday.

The event last year attracted about 360 influential global family office principals, leaders and industry pioneers.

Amid rising geopolitical uncertainty, Hong Kong increasingly stood out as a stable safe haven and preferred hub for wealthy families seeking long-term wealth preservation, Hui said, citing the city’s forward-looking policies, stable system and close alignment with long-term national strategy in an era of uncertainty.

“Industry insiders have pointed out that wealthy investors are reassessing their global asset allocation and are increasingly inclined to channel more of their wealth into Hong Kong in search of a more stable haven,” Hui said.

  • Related Posts

    Chinese robotaxi firms accelerate global roll-outs as cost edge drives expansion

    Chinese robotaxi firms from Pony AI to WeRide are accelerating global roll-outs of commercial fleets, leveraging cost competitiveness from the country’s world-leading new energy vehicle (NEV) supply chain and improved…

    Continue reading
    WuXi AppTec posts record first-quarter revenue on strong global demand

    China’s drug maker WuXi AppTec reported record first-quarter revenue, as a robust order backlog and sustained demand from global pharmaceutical companies supported growth. For the three months ended March 31,…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *